Table of drug concentrations used in this study.

Abstract

<p>Conc. I indicates the concentration used for the model-based KSHV reactivation modeling and for the experiment-based optimization. Conc. II indicates the set of refined concentrations used in the second part of the experiment-based optimization. These concentrations were used in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0020998#pone-0020998-g001" target="_blank">Figures 1</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0020998#pone-0020998-g003" target="_blank">3</a>.</p